17 May 2023 - EMA has published recommendations for industry on good practices to ensure continuity in the supply of ...
19 December 2022 - The European Commission, the Heads of Medicines Agencies and the EMA have published recommendations that aim to ...
29 September 2022 - EMA is launching a pilot to support the translation of basic research developments into medicines that could ...
7 July 2022 - The EMA) has finalised guidance on companion diagnostics, addressing procedural aspects to facilitate consultation between EMA ...
24 May 2022 - As part of its efforts to support a global approach to the development of new antimicrobial medicines, ...
25 February 2021 - EMA has issued guidance outlining the requirements for manufacturers planning to modify their COVID-19 vaccines in ...
2 February 2021 - The European Medicines Agency has released a draft guidance to assist drug developers using its Priority ...
16 September 2020 - The European Medicines Agency is on the verge of releasing revised guidance for advanced therapy medicinal ...
1 July 2020 - EMA has endorsed a joint statement on prioritisation of COVID-19 clinical trials published by the International ...
24 March 2020 - Global regulators have published a report today presenting the outcomes of a workshop on COVID-19 vaccine ...
27 December 2019 - There is a key problem in randomised clinical trials as outcomes can be distorted due to ...
29 August 2019 - Although regulators rarely offer public comments on another regulator’s guidance, the European Medicines Agency (EMA) late ...
3 June 2019 - EMA has released a draft guideline on the quality requirements for medical devices in human medicines ...
8 April 2019 - This article discusses the need to update regulatory science to include the use of minimal residual disease ...
14 January 2019 - EMA has published a PDF revision of its guideline on the evaluation of human medicines ...